Division 22
United Kingdom
Issues regarding labelling and the unblinding of investigational medicinal products shall be addressed in the protocol, where necessary.
United Kingdom
Issues regarding labelling and the unblinding of investigational medicinal products shall be addressed in the protocol, where necessary.